[1]KANG Y,JIN Y,LI Q,et al.Advances in lung cancer driver genes associated with brain metastasis[J].Frontiers in Oncology,2021,10:606300.
[2]SIEGEL RL,MILLER KD,JEMAL A.Cancer statistics,2020[J].CA:A Cancer Journal for Clinicians,2020,70(1):7-30.
[3]DENISENKO TV,BUDKEVICH IN,ZHIVOTOVSKY B.Cell death-based treatment of lung adenocarcinoma[J].Cell Death & Disease,2018,9(2):117.
[4]董智,赵军,柳晨,等.肺癌骨转移诊疗专家共识(2019版)[J].中国肺癌杂志,2019,22(04):187-207.
DONG Z,ZHAO J,LIU C,et al.Expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2019 edition) [J].Chinese Journal of Lung Cancer,2019,22(04):187-207.
[5]XIE S,WU Z,QI Y,et al.The metastasizing mechanisms of lung cancer:Recent advances and therapeutic challenges[J].Biomedicine & Pharmacotherapy,2021,138:111450.
[6]WOOD SL,PERNEMALM M,CROSBIE PA,et al.The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets[J].Cancer treatment reviews,2014,40(4):558-566.
[7]KO J,WINSLOW MM,SAGE J.Mechanisms of small cell lung cancer metastasis[J].EMBO Molecular Medicine,2021,13(1):e13122.
[8]POPPER HH.Progression and metastasis of lung cancer[J].Cancer and Metastasis Reviews,2016,35:75-91.
[9]VICENT S,PERURENA N,GOVINDAN R,et al.Bone metastases in lung cancer.Potential novel approaches to therapy[J].American Journal of Respiratory and Critical Care Medicine,2015,192(7):799-809.
[10]KNAPP BJ,DEVARAKONDA S,GOVINDAN R.Bone metastases in non-small cell lung cancer:A narrative review[J].Journal of Thoracic Disease,2022,14(5):1696.
[11]SONG X,CHENG X,JIN X,et al.EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption[J].Clinical & Experimental Metastasis,2023,40(4):357-371.
[12]MEIER F,BRUNNER AD,FRANK M,et al.diaPASEF:parallel accumulation-serial fragmentation combined with data-independent acquisition[J].Nature Methods,2020,17(12):1229-1236.
[13]GEYER PE,HOLDT LM,TEUPSER D,et al.Revisiting biomarker discovery by plasma proteomics[J].Molecular Systems Biology,2017,13(9):942.
[14]SHI Y,AU JS,THONGPRASERT S,et al.A prospective,molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)[J].Journal of Thoracic Oncology,2014,9(2):154-162.
[15]MIDHA A,DEARDEN S,MCCORMACK R.EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology:a systematic review and global map by ethnicity (mutMapII)[J].American Journal of Cancer Research,2015,5(9):2892.
[16]BROUNS AJWM,HENDRIKS LEL,ROBBESOM-VAN DEN BERGE IJ,et al.Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer[J].Frontiers in Oncology,2023,13:1145001.
[17]ZHOU JZ,RIQUELME MA,GAO X,et al.Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis[J].Oncogene,2015,34(14):1831-1842.
[18]XU J,LI W,XU S,et al.Effect of dermatan sulphate on a C57-mouse model of pulmonary fibrosis[J].Journal of International Medical Research,2019,47(6):2655-2665.
[19]WANG JY,ZHANG W,ROEHRL MW,et al.An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19[J].Journal of Autoimmunity,2021,120:102644.
[20]CHEN JQ,CONTRERAS RG,WANG R,et al.Sodium/potasium ATPase (Na+,K+-ATPase) and ouabain/related cardiac glycosides:a new paradigm for development of anti-breast cancer drugs[J].Breast Cancer Research and Treatment,2006,96(1):1.
[21]SUMIYOSHI S,SHIOZAKI A,KOSUGA T,et al.Functional analysis and clinical importance of ATP1A1 in colon cancer[J].Annals of Surgical Oncology,2023,30(11):6898-6910.
[22]NAKAMURA K,SHIOZAKI A,KOSUGA T,et al.The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer[J].Gastric Cancer,2021,24:1278-1292.
[23]MIJATOVIC T,ROLAND I,VAN QUAQUEBEKE E,et al.The α1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers[J].The Journal of Pathology,2007,212(2):170-179.
[24]YANG P,YANG Y,SUN P,et al.βII spectrin (SPTBN1):biological function and clinical potential in cancer and other diseases[J].International Journal of Biological Sciences,2021,17(1):32.
[25]LORENZO DN,EDWARDS RJ,SLAVUTSKY AL.Spectrins:molecular organizers and targets of neurological disorders[J].Nature Reviews Neuroscience,2023,24(4):195-212.
[26]SHEN C,YU Y,LI H,et al.Global profiling of proteolytically modified proteins in human metastatic hepatocellular carcinoma cell lines reveals CAPN 2 centered network[J].Proteomics,2012,12(12):1917-1927.
[27]GU F,ZHANG Y,LIU Y,et al.Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion,c-Met overexpression,and HER-2 amplification with inherent resistance to crizotinib,chemotherapy,and radiotherapy[J].Journal of Hematology & Oncology,2016,9:1-3.